272 results
8-K
EX-99.2
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
amounts due to rounding.
(1) Europe represents all European Union countries, the European Union accession markets and the United Kingdom.
MERCK
8-K
EX-99.1
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
is currently under review in the European Union and is being evaluated in ongoing Phase 3 trials in additional PAH patient populations.
In oncology
8-K
EX-99.2
puwxd5e0k4rv
1 Feb 24
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
6:39am
8-K
EX-99.2
k176xj8c
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
8-K
EX-99.1
ovg5vl86ljhpb
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
8-K
EX-99.2
n8mmp1mjdi8bn6
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
8-K
EX-99.1
zits8r
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
424B5
mwah28
10 May 23
Prospectus supplement for primary offering
4:27pm
424B5
5jtol40e8t9 4v
8 May 23
Prospectus supplement for primary offering
8:17am